Acquisitions30 Mar 2026, 06:41 pm
Jubilant Ingrevia Completes Acquisition of Remidex Pharma
AI Summary
Jubilant Ingrevia Ltd has completed the acquisition of 100% equity stake in Remidex Pharma Private Limited. This is in continuation to the Share Purchase Agreement entered into with Remidex on March 13, 2026. The key terms of the transaction were previously intimated to the Stock Exchanges. The document related to this acquisition has been uploaded on the company's website.
Key Highlights
- Jubilant Ingrevia Ltd has completed the acquisition of 100% equity stake in Remidex Pharma Private Limited.
- The acquisition was carried out pursuant to a Share Purchase Agreement entered into with Remidex on March 13, 2026.
- The key terms of the transaction were previously intimated to the Stock Exchanges.
- The document related to this acquisition has been uploaded on the company's website.